IMG-EN-AS-62240-01.jpg
Peptides

TAT-NSF222 Fusion Peptide - 1 mg

$383.00
Check your price
  • Cat.Number : AS-62240
  • Availability :
    In stock

Quantity

Add to wishlist Bulk Quote

This sequence is N-ethyl-maleimide-sensitive factor (NSF) peptide connected to 11 amino acid cell permeable human immunodeficiency virus (HIV) transactivating regulatory protein (TAT) domain by Gly-Gly-Gly spacer. This peptide contains NSF domain extending from amino acids 222 to 243, which is directly amino-terminal of the Walker A motif of the D1 domain of NSF. ATPase assay shows that TAT-NSF222 inhibits NSF ATPase activity.

Specifications

Chemistry
Sequence one letter code
  • YGRKKRRQRRR-GGG-LDKEFNSIFRRAFASRVFPPE
Sequence three letter code
  • H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Gly-Leu-Asp-Lys-Glu-Phe-Asn-Ser-Ile-Phe-Arg-Arg-Ala-Phe-Ala-Ser-Arg-Val-Phe-Pro-Pro-Glu-OH
Molecular Mass/ Weight
  • 4240.1
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
  • Peak Area by HPLC ≥95%
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • HIV

Downloads

You may also be interested in the following product(s)

IMG-EN-AS-61204-01.jpg

(Arg)9 - 1 mg

Cat.Number : AS-61204
$81.00 Excl. Tax
IMG-EN-AS-24270-01.jpg

Cell Permeable-Mastoparan Peptide

Cat.Number : AS-24270
$75.00 Excl. Tax
IMG-EN-AS-24175-01.jpg

FITC-LC-Antennapedia Peptide

Cat.Number : AS-24175
$198.00 Excl. Tax

Citations

P2X4-Receptor-Mediated Synthesis and Release of Brain-Derived Neurotrophic Factor in Microglia Is Dependent on Calcium and p38-Mitogen-Activated Protein Kinase Activation

J Neurosci. . 2009 Mar 18 ; 29(11) 3518 | DOI : 10.1523/JNEUROSCI.5714-08.2009

  • T. Trang

A Novel Class of Fusion Polypeptides Inhibits Exocytosis

Mol Pharmacol. . 2004 Dec 17 ; 67(4) 1137 | DOI : 10.1124/mol.104.004275

  • K. Matsushita

References

A novel class of fusion polypeptides inhibits exocytosis.

Mol Pharmacol. . 2004 Dec 17 ; 67(4) 1137 | DOI : 10.1124/mol.104.004275

  • K. Matsushita
  • et al